Prosthetic joint infection caused by Candida lusitaniae: report of a unique case

Acta Clin Belg. 2019 Aug;74(4):286-291. doi: 10.1080/17843286.2018.1511264. Epub 2018 Aug 23.

Abstract

Background: Candida prosthetic joint infection (PJI) is a rare complication of total knee arthroplasty (TKA). The literature regarding its diagnosis and management is scarce. Case summary: We present the case of a 79-year-old woman with history of TKA and femoral intramedullary nailing, who developed PJI caused by Candida lusitaniae. A two-stage exchange arthroplasty was performed. She underwent implant removal, debridement and placement of temporary antibiotic impregnated spacer. Postoperatively, the patient received treatment with micafungin for 24 weeks. Eleven months after the first stage, the spacer was removed and a new knee prosthesis was placed. Complete eradication of infection was demonstrated by negative culture of cement spacer, synovial fluid and periprosthetic tissue. Histology of surgical samples was unremarkable. Empiric treatment with micafungin was given for 6 weeks after placement of the new prosthesis. At 6-month follow-up, there was no evidence of recurrent infection. Conclusion: To our knowledge, this is the first reported case of Candida lusitaniae PJI.

Keywords: Prosthetic joint infection; fungal infection; total knee arthroplasty.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / administration & dosage
  • Arthroplasty, Replacement, Knee / adverse effects
  • Arthroplasty, Replacement, Knee / methods
  • Candida* / drug effects
  • Candida* / isolation & purification
  • Candida* / pathogenicity
  • Debridement / methods*
  • Device Removal / methods*
  • Female
  • Humans
  • Knee Prosthesis / microbiology
  • Micafungin / administration & dosage*
  • Osteoarthritis, Knee / surgery
  • Prosthesis-Related Infections* / diagnosis
  • Prosthesis-Related Infections* / drug therapy
  • Prosthesis-Related Infections* / microbiology
  • Prosthesis-Related Infections* / surgery
  • Reoperation / methods*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Micafungin